Dual Diagnosis - PowerPoint PPT Presentation

1 / 42
About This Presentation
Title:

Dual Diagnosis

Description:

ASPD 14% 18% Drug treatment intake. NTORS (Gossop et al 1998) New ... severe dependence, ASPD, polysubstance abuse. Bi-polar disorder. Alcohol dependence common ... – PowerPoint PPT presentation

Number of Views:1793
Avg rating:3.0/5.0
Slides: 43
Provided by: W2KU7
Category:
Tags: aspd | diagnosis | dual

less

Transcript and Presenter's Notes

Title: Dual Diagnosis


1
Dual Diagnosis
  • Dr. Louise Sell
  • Greater Manchester West Mental Health NHS
    Foundation Trust

2
THE PROBLEM
POLICY
MANAGE-MENT
TREAT-MENT
3
THE PROBLEM
4
Dual diagnosis / co-morbidity
  • a primary psychiatric illness precipitating or
    leading to substance misuse
  • substance misuse worsening or altering the course
    of a psychiatric illness
  • substance misuse leading to psychiatric symptoms
    or illnesses.
  • Intoxication, withdrawal, problem use, harmful
    use, dependence

5
(No Transcript)
6
Epidemiological Catchment Area study - I
  • Frequency of lifetime substance misuse disorder
  • ASPD 83
  • Bipolar 60
  • Schizophrenia 47
  • Panic disorder 36
  • Depression 27
  • Anxiety 24
  • No mental illness 13

7
Epidemiological Catchment Area study - II
  • Frequency of lifetime psychiatric disorders
  • alcohol other drugs
  • Depression 13 26
  • Anxiety 20 28
  • Schizophrenia 4 7
  • ASPD 14 18

8
Drug treatment intake
  • NTORS (Gossop et al 1998)
  • New admissions, past 3 months
  • 29 suicidal thoughts
  • 10 psychiatric hospital admission

9
Multiple morbidity in drug and alcohol treatment
  • Weaver 2002
  • Past year psychiatric disorder in drug services
    75, alcohol 85.
  • 30 multiple morbidity
  • 39 drug users with psychiatric disorder received
    no treatment for it

10
Multiple morbidity in psychiatric treatment
Weaver et al 2002
  • Patients of mental health services, past year
  • Hazardous / harmful drinking 25
  • Problem drug use 31
  • Cannabis past year 25
  • Poly drug use 13
  • Opiates 5
  • Dependent on one or more drug 17
  • Very low level substance related intervention by
    mental health team or by specialist drug and
    alcohol services.

11
Reasons for substance misuse in those with
mental health problems
  • Self-medication
  • Same reasons as for other people
  • Availability
  • Access to a social group
  • Relief from boredom/ inactivity
  • Coping with stressful relationships
  • Coping with stressful situations

12
Not just dual diagnosis.
  • venous or arterial thrombosis
  • blood-borne infections including HIV and
    Hepatitis B and C
  • cardiac disease
  • Smoking substances..respiratory disease
    including pneumonia and emphysema
  • Alcohol - Korsakoffs syndrome, delirium and
    seizures.

13
Consequences of co-morbidity
  • Poor prognosis
  • Increased relapse
  • Increased hospitalization
  • Greater service utilization
  • Higher costs
  • Increased risk HIV
  • Less compliance with treatment
  • Increased suicide rates
  • Violence
  • Criminality
  • Housing instability
  • Poorer social functioning
  • Adverse impact carers, family
  • Marginalization
  • Poverty

14
National enquiry into homicides and suicides
  • A review of inquiries into homicides committed by
    people with a mental illness identified substance
    misuse as a factor in over half the cases, and
    substance misuse is over-represented among those
    who commit suicide

15
POLICY
16
Mainstreaming
  • Substance misuse is usual rather than exceptional
    amongst people with severe mental health problems
  • Individuals with these dual problems deserve high
    quality, patient focused and integrated care.
  • This should be delivered within mental health
    services. This policy is referred to as
    mainstreaming.

17
Mainstreaming
  • local services develop focused definitions of
    dual diagnosis which reflect local patterns of
    need and clarify the target group for services
  • Agree definitions between relevant agencies
  • specialist teams of dual diagnosis workers should
    provide support to mainstream mental health
    services
  • all staff in assertive outreach teams must be
    trained and equipped to work with dual diagnosis
  • all services, including drug and alcohol
    services, must ensure that clients with severe
    mental health problems and substance misuse are
    subject to the Care Programme Approach and have a
    full risk assessment.
  • integrated care delivered by one team appears
    to deliver better outcomes than serial care or
    parallel care .. Integrated treatment can be
    delivered by .. mental health services following
    training and with support from substance misuse
    services

18
Co-morbidity in prisons
  • Prisons have a high prevalence of drug dependency
    and dual diagnosis
  • Forensic team
  • MH in-reach
  • Drug treatment
  • CARAT
  • IDTS
  • ? Specialist team

19
Care Programme Approach (Oct 2008)
  • Single CPA process (replacing the old enhanced
    and standard CPA system).
  • Ensures care planned and co-ordinated. Substance
    misuse care plan sits within CPA process
  • CPA as default (DH 2008)
  • parenting responsibilities
  • caring responsibilities
  • dual diagnosis (substance misuse)
  • history of violence or self harm
  • in unsettled accommodation.

20
Mental Health Act 2007
  • any disorder or disability of the mind
  • Includes sexual deviancy
  • Includes personality disorder
  • Excludes dependence

21
Personality disorder No longer a diagnosis of
exclusion (NIMHE, 2003)
  • Personality disorder qualifies for treatment via
    mental health services
  • Majority undiagnosed
  • Co-morbidity with another serious mental health
    problem common
  • Co-morbidity with substance misuse common
  • Adverse outcomes.

22
MANAGEMENT
23
Drug misuse and dependence UK guidelines on
clinical management 2007
  • Given the high prevalence of mental health
    difficulties, the majority attending substance
    misuse services will have mental health needs
    that need treatment and if not appropriately
    managed may affect outcome and retention in
    services.

24
Strathdee et al 2002, Dual diagnosis in a primary
care group (PCG) A step by step epidemiological
needs assessment and design of a training and
service response model.
  • Most substance misuse clients would not have
    sufficient mental health problems for eligibility
    at community mental health teams which prioritise
    those with severe and enduring mental illness. It
    is recommended that the majority with mild and
    moderate mental health problems should be managed
    by specialist substance misuse services and or
    primary care or by counselling services. Staff
    training may be required.

25
Management of co-morbidity
  • Care planning, care-coordination
  • Joint working / liaison / referral to mental
    health services
  • primary care psychology
  • primary care mental health
  • crisis resolution HTT
  • early intervention
  • CMHT)
  • in house management of mild to moderate mental
    health problems

26
Management in house
  • Diagnostic uncertainty
  • difficult presentation, unable to abstain
  • Patient refusal or inability to engage with
    others
  • Barriers to referral to primary or secondary care
    services
  • commissioning
  • service personnel attitude / beliefs
  • diagnostic disagreement

27
We Can Manage in House?
  • Assess
  • Diagnose
  • Prescribe
  • ? Psychological therapy
  • ? Social care
  • ? Housing
  • ? Employment

28
Workforce
  • Match needs of patient to skill and competency of
    clinical team, minimise multiple referrals and
    teams
  • Substance misuse competence in mental health
    staff
  • Mental health competence in substance misuse staff

ITEP
29
TREATMENT
30
Treatment of co-morbidity
  • Mental health and substance misuse problems
    common Physical morbidity also
  • The literature
  • few RCTs, small sample size, short follow up.
  • Primary or secondary?
  • Does it really matter?

31
Treatment of co-morbidity
  • 3 4 weeks abstinence
  • Complete substance history
  • blood / urinalysis
  • Comprehensive history
  • chronology, mental health symptoms during
    abstinence, family history
  • Medication, drug interactions
  • Risk of self harm

32
Alcohol depression
  • Tri-cyclics, mixed results, no clear benefit,
    risks of drug interaction, toxicity.
  • SSRI, doses higher than routine, mixed results
    but overall modest beneficial effect.
  • Nunes Levin, 2004, meta-analysis of placebo
    controlled trials of treating depression in
    alcohol or drug dependence.
  • Anti-depressants modest benefit
  • Only minimal benefit to substance misuse
  • Concurrent treatment substance misuse needed
  • Waiting a week improves response rate
  • Prescribe SSRIs where clear depression, regualr
    review effectiveness, compiance, adverse effects.

33
Opioids depression
  • Studies often complicated by use of cocaine.
  • As for alcohol, modest benefit on depression, not
    necessarily on substance use.

34
Cocaine depression
  • On-going use likely to affect mood, risk of self
    harm.
  • Anti-depressants may reverse / ameliorate the
    reduction in DA, NA, 5HT caused by cocaine
  • Included in Nunes Levin meta-analysis
  • SSRI / TCA improve depression but not cocaine
    use, may reduce craving. TCA increased risk
    toxicity / interactions

35
Nicotine
  • Commonly abused by those with mental illness
  • Tendency to heavy smoking
  • Review of smoking cessation studies in those with
    mental illness(el Guebaly et al 2002)
  • Pharmacotherapy / psychoeducational
  • Similar quit rate outcomes to other groups
  • ? No effect of making hospitals smoke -free

36
Alcohol anxiety
  • Anxiety / alcohol diagnostic difficulty,
    anxiety feature withdrawal
  • Buspirone not shown to improve anxiety or
    drinking
  • SSRI first choice
  • Caution benzodiazepines
  • Esp. severe dependence, ASPD, polysubstance abuse

37
Bi-polar disorder
  • Alcohol dependence common
  • Valproate more acceptable (Li, warning no
    alcohol)
  • Cocaine abuse
  • ?lamotrigine improved mood , drug craving but not
    drug use
  • Quetiapine adjunct improved mood, craving and use

38
Schizophrenia
  • ? Typical anti-psychotics may contribute to
    illicit drug use
  • Atypical anti-psychotic treatment may be
    associated with better substance misuse outcomes
  • Clozapine may confer additional benefit

39
PSI for severe mental illness
  • Systematic review of RCTs Cleary et al 2008
  • Diversity of interventions, outcome measures,
    trial quality
  • CBT, MI, group therapy, integrated ACT, intensive
    case management, residential programmes, CM,
    forensic settings

40
  • MI highest quality evidence of reduced
    substance in short term
  • MI CBT, also improvement in mental state
  • Long term integrated residential reduced
    substance misuse
  • CM 3 RCTs reduced substance misuse, 1 RCT
    CMMICBT increased retention and drug free urines

41
www.lifeline.org.uk
  • Mental health and
  • Cannabis
  • Ecstasy
  • Alcohol and other drugs
  • Heroin and crack

42
THANK YOU
Write a Comment
User Comments (0)
About PowerShow.com